EUVIMEDEUVIMED entdecken
Open Access

Clinical and Genomic Characterization of a Cohort of Patients With Klebsiella pneumoniae Bloodstream Infection

David J Roach iD, Sushmita Sridhar iD, Elizabeth Oliver, Sowmya R Rao, Damien M Slater, Wontae Hwang, Kian Hutt Vater, Anupama Dinesh, Firdausi Qadri, Mohammod J Chisti, Virginia M Pierce, Sarah E Turbett iD und 5 weitere

Clinical Infectious Diseases · 25.01.2024 · 78 (1) · 31-39

DOI: 10.1093/cid/ciad507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 26.08.2023. Verfasst von David J Roach und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Broad Institute of MIT and Harvard, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Cross Infection, Bacteremia, Klebsiella Infections, Sepsis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The clinical and microbial factors associated with Klebsiella pneumoniae bloodstream infections (BSIs) are not well characterized. Prior studies have focused on highly resistant or hypervirulent isolates, limiting our understanding of K. pneumoniae strains that commonly cause BSI. We performed a record review and whole-genome sequencing to investigate the clinical characteristics, bacterial diversity, determinants of antimicrobial resistance, and risk factors for in-hospital death in a cohort of patients with K. pneumoniae BSI.

Methods

We identified 562 patients at Massachusetts General Hospital with K. pneumoniae BSIs between 2016 and 2022. We collected data on comorbid conditions, infection source, clinical outcomes, and antibiotic resistance and performed whole-genome sequencing on 108 sequential BSI isolates from 2021 to 2022.

Results

Intra-abdominal infection was the most common source of infection accounting for 34% of all BSIs. A respiratory tract source accounted for 6% of BSIs but was associated with a higher in-hospital mortality rate (adjusted odds ratio, 5.4 [95% confidence interval, 2.2–12.8]; P < .001 for comparison with other sources). Resistance to the first antibiotic prescribed was also associated with a higher risk of death (adjusted odds ratio, 5.2 [95% confidence interval, 2.2–12.4]; P < .001). BSI isolates were genetically diverse, and no clusters of epidemiologically and genetically linked cases were observed. Virulence factors associated with invasiveness were observed at a low prevalence, although an unexpected association between O-antigen type and the source of infection was found.

Conclusions

These observations demonstrate the versatility of K. pneumoniae as an opportunistic pathogen and highlight the need for new approaches for surveillance and the rapid identification of patients with invasive antimicrobial-resistant K. pneumoniae infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross InfectionBacteremiaKlebsiella InfectionsSepsisHumansKlebsiella pneumoniaeHospital MortalityAnti-Bacterial AgentsGenomics

Stichwörter der Autor:innen

Klebsiella pneumoniaebacteremiamortality modelingvirulence factorswhole-genome sequencing

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • The Broad Institute of MIT and Harvard, Boston, Massachusetts, USA.
  • Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Global Health, Boston University, Boston, Massachusetts, USA.
  • Dhaka Hospital, International Centre for Diarrheal Disease Research, Bangladesh.
  • Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.

ORCID-Profile: David J Roach, Sushmita Sridhar, Sarah E Turbett, Colin J Worby, Regina C LaRocque

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Center for Global Health Research Development Award
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Roach, D. J., Sridhar, S., Oliver, E., Rao, S. R., Slater, D. M., Hwang, W., Hutt Vater, K., Dinesh, A., Qadri, F., Chisti, M. J., Pierce, V. M., Turbett, S. E., Bhattacharyya, R. P., Worby, C. J., Earl, A. M., LaRocque, R. C., & Harris, J. B. (2024). Clinical and Genomic Characterization of a Cohort of Patients With Klebsiella pneumoniae Bloodstream Infection. Clinical Infectious Diseases, 78(1), 31-39. https://doi.org/10.1093/cid/ciad507

Vancouver

Roach DJ, Sridhar S, Oliver E, Rao SR, Slater DM, Hwang W, et al. Clinical and Genomic Characterization of a Cohort of Patients With Klebsiella pneumoniae Bloodstream Infection. Clinical Infectious Diseases. 2024;78(1):31-39. doi:10.1093/cid/ciad507

BibTeX
@article{Roach2024,
  author = {Roach, David J and Sridhar, Sushmita and Oliver, Elizabeth and Rao, Sowmya R and Slater, Damien M and Hwang, Wontae and Hutt Vater, Kian and Dinesh, Anupama and Qadri, Firdausi and Chisti, Mohammod J and Pierce, Virginia M and Turbett, Sarah E and Bhattacharyya, Roby P and Worby, Colin J and Earl, Ashlee M and LaRocque, Regina C and Harris, Jason B},
  title = {Clinical and Genomic Characterization of a Cohort of Patients With Klebsiella pneumoniae Bloodstream Infection},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {78},
  number = {1},
  pages = {31--39},
  doi = {10.1093/cid/ciad507}
}
Kostenlos starten →